Paper32010567
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
Mandaliya H and 3 others. Transl Lung Cancer Res, 2019. Cited by 335 papers, by iCite.
Cite this record
ConductScience Library. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Papers, record 32010567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32010567
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12966420 | Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12966420 | PubMed |
| 2 | 24927957 | Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet. | Med Oncol | 2014 | https://conductscience.org/library/papers/24927957 | PubMed |
| 3 | 26205001 | Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. | Sci Rep | 2015 | https://conductscience.org/library/papers/26205001 | PubMed |
| 4 | 22855161 | Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. | Clin Transl Oncol | 2012 | https://conductscience.org/library/papers/22855161 | PubMed |
| 5 | 28929586 | Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017. | Asia Pac J Clin Oncol | 2018 | https://conductscience.org/library/papers/28929586 | PubMed |
| 6 | 11229684 | Inflammation and cancer: back to Virchow? | Lancet | 2001 | https://conductscience.org/library/papers/11229684 | PubMed |
| 7 | 15346996 | Greater risks of chemotherapy toxicity in elderly patients with cancer. | J Support Oncol | 2003 | https://conductscience.org/library/papers/15346996 | PubMed |
| 8 | 12490959 | Inflammation and cancer. | Nature | 2002 | https://conductscience.org/library/papers/12490959 | PubMed |
| 9 | 29356383 | Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer? | Clin Respir J | 2018 | https://conductscience.org/library/papers/29356383 | PubMed |
| 10 | 23530866 | Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23530866 | PubMed |
| 11 | 27025911 | Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients. | Sci Rep | 2016 | https://conductscience.org/library/papers/27025911 | PubMed |
| 12 | 30620402 | Cancer statistics, 2019. | CA Cancer J Clin | 2019 | https://conductscience.org/library/papers/30620402 | PubMed |
| 13 | 26779364 | Geriatric oncology: problems with under-treatment within this population. | Cancer Biol Med | 2015 | https://conductscience.org/library/papers/26779364 | PubMed |
| 14 | 18214060 | Long-term survivors after chemotherapy in advanced non-small cell lung cancer. | Anticancer Res | 2007 | https://conductscience.org/library/papers/18214060 | PubMed |
| 15 | 26955285 | Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/26955285 | PubMed |
Cited by282
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958623 | Systemic Inflammatory Indices and Hearing Loss in U.S. Adults Aged 40-85 Years: A Serial Cross-Sectional Study 1999-2020. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/42958623 | PubMed |
| 42930159 | Baseline and Dynamic Clinical-Laboratory Risk Models for Early Progression or Death During PD-(L)1 Blockade in Advanced NSCLC: Development and Internal Validation. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930159 | PubMed |
| 42501018 | Diagnostic Management of Asymptomatic Pulmonary Embolism: A Predictive Model Integrating Inflammatory Markers and Clinical Characteristics in Patients With Deep Vein Thrombosis. | Clin Appl Thromb Hemost | 2026 | https://conductscience.org/library/papers/42501018 | PubMed |
| 42488103 | Levels of chronic systemic inflammation markers in patients with multi-stages of esophageal and gastric lesions. | Front Oncol | 2026 | https://conductscience.org/library/papers/42488103 | PubMed |
| 42445435 | Association between pan-immune-inflammation value and prognosis in lung cancer patients: a systematic review and meta-analysis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445435 | PubMed |
| 42433165 | Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study. | Ann Clin Transl Neurol | 2026 | https://conductscience.org/library/papers/42433165 | PubMed |
| 42428338 | Association of Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) With Molecular Subtypes of Breast Cancer. | Iran J Pathol | 2026 | https://conductscience.org/library/papers/42428338 | PubMed |
| 42273683 | Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients. | Front Immunol | 2026 | https://conductscience.org/library/papers/42273683 | PubMed |
| 42261002 | Peripheral blood inflammatory indices and their association with hospitalization status in acute exacerbation of chronic obstructive pulmonary disease: A retrospective observational study. | J Int Med Res | 2026 | https://conductscience.org/library/papers/42261002 | PubMed |
| 42145953 | Correlations between inflammatory biomarkers and clinicopathological features in surgically resected thymic epithelial tumors: implications for preoperative diagnosis. | PeerJ | 2026 | https://conductscience.org/library/papers/42145953 | PubMed |
| 42125693 | The impact of inflammation on the incidence of different pathological types of lung cancer: the Kailuan study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42125693 | PubMed |
| 42022321 | Associations of three immune inflammatory markers with the risk of brain metastasis from lung cancer: a systematic review and meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42022321 | PubMed |
| 42014920 | Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single-Center Study. | Cancer Med | 2026 | https://conductscience.org/library/papers/42014920 | PubMed |
| 41979751 | Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41979751 | PubMed |
| 41977057 | The Role of Nutritional and Inflammatory Indices in Predicting Prognosis in Older Adults Undergoing Radiotherapy for Lung Cancer: NIRT-LC Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41977057 | PubMed |
| 41939190 | Prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index in surgically treated non-small cell lung cancer. | Front Nutr | 2026 | https://conductscience.org/library/papers/41939190 | PubMed |
| 41901549 | Prognostic Value of Systemic Inflammation Markers (NLR and Haemoglobin) in Non-Small Cell Lung Cancer: Survival Analysis from a Real-World Single-Centre Cohort Study. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41901549 | PubMed |
| 41899290 | Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma. | J Clin Med | 2026 | https://conductscience.org/library/papers/41899290 | PubMed |
| 41803760 | The prognostic value analysis of PIV, PLR, LMR, NPR, and NLR in hilar cholangiocarcinoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41803760 | PubMed |
| 41798482 | Prognostic Significance of Bone Marrow Computed Tomography Attenuation in Patients With Non-small Cell Lung Cancer Without Curative Surgery. | Cureus | 2026 | https://conductscience.org/library/papers/41798482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32010567
GET https://conductscience.org/api/papers/v1/32010567/cited_by?page=2